• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Cardiac troponin I gene mutation in patients with hypertrophic cardiomyopathy

Research Project

Project/Area Number 11670665
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionKanazawa University

Principal Investigator

SHIMIZU Masami  Kanazawa University, Graduate School of Medical Science, Associate Professor, 大学院・医学系研究科, 助教授 (20183402)

Project Period (FY) 1999 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥3,100,000 (Direct Cost: ¥3,100,000)
Fiscal Year 2001: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 2000: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 1999: ¥1,400,000 (Direct Cost: ¥1,400,000)
KeywordsCardiac troponin I / Mutation / Hypertrophic cardiomyopathy
Research Abstract

We examined 270 consecutive unrelated probands with hypertrophic cardiomyopathy (HCM) who underwent genetic analysis, a 12-lead electrocardiography (ECG), and echocardiography. Informed consent was obtained from all subjects or from the parents of minors participating in the study.
DNA was isolated from peripheral white blood cells of all subjects. In vitro amplification of genomic DNA was performed via polymerase chain reaction. Single-strand conformational polymorphism (SSCP) analysis of amplified DNA was then performed. For abnormal SSCP pattern, DNA sequences were determined by the Dye Terminator Cycle Sequencing method using an automated fluorescent sequencer. The lysine 183 deletion (K183del) mutation in the cardiac troponin I (cTnl) gene was identified in 10 of 270 probands with HCM. Family members of the affected probands were evaluated similarly after informed consent was obtained.
In the carrier subjects, ECG abnormalities were initially noted during the early teenage years. Abnormal Q waves were found first and were frequently observed in leads II, III, aVF, V5 and V6 in teenage patients. On the other hand, wall hypertrophy became noticeable only in their late teens, and echocardiographic abnormalities appeared later than ECG abnormalities. HCM caused by the K183del mutation in the cTnl gene has a high disease penetrance in subjects over 20 years of age. About 30% of patients with HCM caused by a K183del mutation in the cTnl gene developed systolic dysfunction after 40 years of age. The change in interventricular septal thickness and the change in % fractional shortening were significantly correlated.

Report

(4 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • 1999 Annual Research Report
  • Research Products

    (10 results)

All Other

All Publications (10 results)

  • [Publications] Hiromasa Kokado: "Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene"Circulation. 102. 663-669 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masami Shimizu: "Chronologic electrocardiographic changes in patients with hypertrophic cardiomyopathy associated with cardiac troponin I mutation"American Heart Journal. 143. 289-293 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masami Shimizu: "Septal wall thinning and systolic dysfunction in patients with hypertrophic cardiomyopathy caused by a cardiac troponin I gene mutation"American Heart Journal. 143(印刷中). (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masami Shimizu: "T-peak to T-end interval is a better predictor of high risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion"Clinical Cardiology. 25(印刷中). (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Hiromas Kokado: "Clinical features of hypertrophic cardiomyopathy caused by a Lysl83 deletion mutation in the cardiac troponin I gene"Circulation. 102-6. 663-669 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masami shimizu: "Chronologic electrocardiographic changes in patients with hypertrophic cardiomyopathy associated with cardiac troponin I mutation"American Heart Journal. 143-2. 289-293 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masami Shimizu: "Septal wall thinning and systolic dysfunction in patients with hypertrophic cardiomyopathy caused by a cardiac troponin I gene mutation"American Heart Journal. 143(in press). (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masami Shimizu: "T-peak to T-end interval is a better predictor of high risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion"Clinical Cardiology. 25(in press). (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Masami Shimizu: "Chronologic electrocardiographic changes in patients with hypertrophic cardiomyopathy associated with cardiac troponin I mutation"American Heart Journal. 143・2. 289-293 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] Masami Shimizu: "Septal wall thinning and systolic dysfunction in patients with hypertrophic cardiomyopathy caused by a cardiac troponin I gene mutation"American Heart Journal. 143・(印刷中). (2002)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2025-11-20  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi